Importance of surrogate endpoints - focus on Proteinuria! @ASNKidney ▶️ Proteinuria and Podocyte loss mechanisms 🐙 ▶️ Accelerated drug approval 🚀 ▶️ A call to Action! by @kirkcampbell - PARASOL results and future expansion 🌟 #KidneyWk #ISGDTweets #GlomerularDisease

Oral Abstract Session 🌟 ▶️ The greater the reduction in Proteinuria, the better the outcomes in IgA Nephropathy! 🔑 ▶️ Outcomes across diseases and age in the CureGN cohort! 👏 #KidneyWk #ISGDTweets #GlomerularDisease

Outstandining talk by @AstridWeins on anti-nephrin antibodies ▶️ Anti-nephrin Ab provides diagnostic value, guide treatment and define prognosis ▶️ Refined techniques and appropriate treatment-related timing measurement is crucial 🧪 #KidneyWk #ISGDTweets #GlomerularDisease

Innovative initiatives in Pediatric NS! ▶️ PARASOL provides a regulatory path for new drugs by proving proteinuria as a marker 🌟 and is expanding to APOL-1-mediated KD and MN! 🚀 ▶️ NEPTUNE Match moving towards personalized medicine 🎯 #KidneyWk #ISGDTweets #GlomerularDisease

Pediatric Nephrotic Syndrome Translational Session ▶️ Diverse Immunological Architecture! ▶️ Recent focus on novel autoantibodies 🎯 ▶️ GWAS + composite HLA-PRS in the search of a unified disease mechanism 🧬 #KidneyWk #ISGDTweets #GlomerularDisease

B-cell depleting strategies in lupus nephritis 🐺 ▶️ Obinutuzumab confers higher complete remission rates vs other mAbs ▶️ Immunological reset 🆕 CAR-T cells - deeper depletion in varied differentiation stages (for refractory cases!) #KidneyWk #ISGDtweets #GlomerularDisease

The role of B-cells in lupus nephritis by @AugustoVaglio 🐺 ▶️ B-cell activation and expanison ▶️ B-cell overdifferentiation and hiperreactivity ▶️ Isolated germinal centers #KidneyWk #ISGDtweets #GlomerularDisease

Thrombotic microangiopathy in children - extensive differential @SethiRenalPath! ▶️ From STEC-HUS, TTP to atypical HUS genetics! 🧬 ▶️ C3G and DDD involve distinct complement components - ApoE! ▶️ Searching for aHUS specific markers 🔍 #KidneyWk #GlomerularDisease

Membranous Nephropathy is not Adult-exclusive #ASN2025! ▶️ Pediatric patients are not 'little adults' @JeanHouMD - different clinical profiles, many unknown antigens! 🌟 ▶️ Hot insights into new pediatric MN antigens @SethiRenalPath - Poster Pearls 👀 #GlomerularDisease

Yesterday's highlights: IgA Nephropathy at Plenary Session! ▶️ 1. Impact of new tools by Dr. Vlado Perkovic - first #ASN2025 publication @kidneyint.bsky.social! 🔥 ▶️ 2. Just published @nejm.org - Dr. Richard Lafayette on the ORIGIN 3 trial: Atacicept led to remarkable results! 🤯 #GlomerularDisease

Spreading the word about the Importance and Power of Podocytes at @asnkidney.bsky.social Kidney Week in Houston. @isgd.bsky.social

ASN begins with an inspiring speech from Dr. Prabir Roy-Chaudhury, ASN president. A standing ovation for the new landscape of clinical trials in GD. ISGD is on the ground and will be reporting on the latest in GD. Follow and join the conversation. #ASN2025 #GlomerularDisease

What an inspiring week at ESPN 2025 in Athens! We’re energized by powerful conversations with pediatric nephrology experts from 57 countries, and grateful to the ESPN team for uniting our global community. #ESPN2025 #PediatricNephrology #ClinicalTrials #ISGD

📣 Are you ready for the newest in IgAN? Join ISGD and Travere Therapeutics on Friday, October 24 at 12:00 PM ET for "PROTECTing What Matters: Targeting Endothelin-1 and Angiotensin II in IgA Nephropathy to Preserve Kidney Function." Secure your spot: events.zoom.us/ev/AiBA7aMWF...

📢 A TSUNAMI of pediatric kidney clinical trials is upon us! 🌊 At @ESPNSociety in Athens, we kickstarted Time To Train, a Clinical Trialist Bootcamp to inspire the next generation of PIs and demystify the process! In the golden age of nephrology, no child will be left behind!

The Time to Train team is present at ESPN in Athens, gearing up to educate the upcoming generation of clinical trialists. This timely initiative will serve as a crucial step towards the future of patient care and treatment. #ESPN2025 #TimeToTrain #ISGD #ClinicalTrials

⛱️ At day 2 of the PARASOL Kickoff, experts united in a commitment to refine trial endpoints in APOL1 kidney disease & MN. A global effort through data sharing and collaboration! www.is-gd.org/en/news-from... #KidneyResearch #Innovation #AMKD #membranousnephropathy #KidneyHealth

Laura Mariani recapping PARASOL-FSGS project to a full house in Minneapolis as we kick off PARASOL MN and APOL1 projects! (PS we have diagnosed the carpet with Fabry disease) @miktmc.bsky.social @tobias-b-huber.bsky.social @jarcyzphd.bsky.social @utoronto.ca #APOL1nephropathy #MembranousNephropathy

PARASOL Project is expanding focus to include biomarkers & endpoints in APOL1 kidney disease and primary MN as well as FSGS. Learn more: eu1.hubs.ly/H0nr8Lv0 @tobias-b-huber.bsky.social @miktmc.bsky.social @jarcyzphd.bsky.social @ohiostatemed.bsky.social @utoronto.ca @nu-nephrology.bsky.social

Hamburg News: Study by Jan Czogalla & @puellesv.bsky.social & collaborators introduces a metabolically enhanced buffer + perfusion technique - opening a new avenue for kidney transplant organ preservation. @isgd.bsky.social

Today on C3G Awareness Day, we spotlight our SEISMIC initiative where ISGD, NephCure, and CompCure convened leading experts at the SEISMIC summit to advance C3G diagnosis and treatment. Watch the highlights: youtu.be/GJvgbtMT3xA youtu.be/Un02dFXyn-w #C3GAwarenessDay #C3G #ISGD #NephCure #CompCure

On this #C3GAwarenessDay, check out: 📺 Hot Topics in GN Online Symposium with the Indian Society of Nephrology: www.youtube.com/live/E0PnEj8... 🔊 Latest GN in 10 Podcast w/Carla Nester, focusing on C3G and complement-mediated diseases: www.is-gd.org/podcast #C3G #GlomerularDisease #ISGD

Today is #C3GAwarenessDay! At ISGD, we stand with people living with this rare kidney disease. As a medical society for #GlomerularDisease experts, we're committed to raising awareness and moving the science forward to bring more hope and solutions to the C3G community. #C3G #ISGD

Calling all ESPN Attendees! 🚀 Announcing Time To Train: Clinical Trials Bootcamp for Investigator Training. Empowering nephrologists to lead groundbreaking trials in kidney disease. Join us, for hands-on training & mentorship: www.is-gd.org/time-to-trai... #TimeToTrain #ESPN2025

We’re thrilled to be in Toronto presenting a Glomerular Disease Preceptorship in partnership with @sickkidsto.bsky.social and @utoronto.ca — Thanks to Christoph Licht and Heather Reich for organizing this outstanding program!

ISGD was at #NephCureHillDay2025 yesterday advocating for the New Era Act, maintaing current NIH funding and preserving the NIDDK. The act aims to advance #GlomerularDisease research and treatments. Learn more: nephcure.org/get-involved...

Day 2 of SEISMIC ✅ Participants agreed on strategies for quicker and more precise diagnosis, aiming for disease-modifying therapies as the primary treatment. Stay tuned for our summary paper and workgroup developments. As Dr. Carla Nester said, “Get ready for SEISMIC change.” 🌋

Day 1️⃣ of the SEISMIC C3G and IC-MPGN focused on improving the future for those affected by C3G and IC-MPGN. Highlights include the urgency to accelerate diagnosis and treatment, alongside the significance of biomarkers and centers of excellence. Today's insights were powerful💥.

🌋The SEISMIC meeting has ignited at our kickoff dinner. Tomorrow we will begin discussions on important issues in the shifting C3G and IC-MPGN landscape. #GlomerularDisease #C3G #ICMPGN #SEISMIC

🎙️World-renowned complement expert Carla Nester joins Koyal Jain and @kdjhaveri.bsky.social on GN in Ten to talk C3G and all things complement-mediated kidney disease share.transistor.fm/s/67f1e0de 🔜 More C3G insights on the way after this week's SEISMIC summit is-gd.org/seismic-summit

Check out all the abstracts from last month's #PodocyteConference karger.com/gdz/article/... and stay tuned for publication of the full meeting report! @tobias-b-huber.bsky.social @ksusztak.bsky.social @genetickidneydoc.bsky.social @dukekidney.bsky.social

Want to become a pro in statistical analysis? Know someone who might be interested in Biostatistics graduate programs? 📈🧮🖥️🎓 Share and come to the @upenn.edu @dbei-upenn.bsky.social Open House on 9/12/25. Registration is *free* and you could even win some swag! www.med.upenn.edu/ggeb/biostat...

Nice video! From the 15th #PodocyteConference in #Hamburg @isgd.bsky.social @tobias-b-huber.bsky.social #FSGS #rFSGS #APOL1 #NephSky #MedSky youtube.com/watch?v=Y6wo...

It truly was an amazing conference! #podocyteconference #Medsky #Nephsky #Skyneph #FSGS #rFSGS #APOL1 @isgd.bsky.social @tobias-b-huber.bsky.social

The podocyte conference in Hamburg was outstanding at all levels- science, innovation, speakers and venue. Many thanks to the organizers and to Hamburg, Germany for providing the perfect destination for an international meeting focusing on podocytes and on glomerular disease.

At the #PodocyteConference you don’t meet only great scientists, but also interesting personalities, like Brian Kennedy, 4-times Grammy award winner and patient advocate. With Matt Sampson & Elena Martinelli #NephSky #SkyNeph @kidneyomicsamps.bsky.social #FSGS #rFSGS #APOL1 @isgd.bsky.social

Huge shoutout and thank you to our dynamic Podocyte Social Media Team - Gabriela Amador Reyes and António Da Silva Inácio. They kept our community buzzing with constant updates and important insights! #PodocyteConference #ISGD

🎉 Thank you for joining us in Hamburg at the 15th International #PodocyteConference and inaugural ISGD Meeting! 🐙 Nearly 500 participants, outstanding science, and electrifying connections among the glomerular disease and kidney health community. https://www.youtube.com/watch?v=Y6wowm4Zgag

More from the #podocyte2025 with @kidneyomicsamps.bsky.social and Laura Mariani #podocyte #hamburg #FSGS #rFSGS #genetics #Nephsky #Medsky #Skyneph @isgd.bsky.social

Meet our distinguished international and multidisciplinary leadership and team of ISGD COE-GD Evaluators! They are ready to move GD care forward. Read our full press release here 👉 bit.ly/COE-GD #ISGD #GlomerularDisease #COEGD #CentersOfExcellence

Exciting news! 🌟 The ISGD Centers of Excellence in Glomerular Disease (COE-GD) criteria have been finalized after 2+ years of meticulous work. Read our full press release here and learn about our commitment to advance GD care, research, and advocacy! 👉 bit.ly/COE-GD #ISGD #GlomerularDisease #COEGD

💫 KEYNOTE LECTURE 💫 Prof. @KretzlerM brilliant lecture! 🔥 Retrieving disease information to get back to patients through the NEPTUNE Network 🎯 Full circle 1999-2025 🔄 #PodocyteConference 🐙 tobias-b-huber.bsky.social

Can we predict and prevent Lupus Nephritis? 🔥 Prof. Julia Weinmann-Menke talked about the incredible Lupus Trial Network, the ReBioLupus project and future perspectives at the #PodocyteConference 🐙 tobias-b-huber.bsky.social

Obinutuzumab in Lupus Nephritis - REGENCY trial @nejm 🔥 New data by @BradRovin 🆕 #PodocyteConference 🐙 effects regardless of IFN 1 status, biomarker analysis and a dive into differences vs CAR-T cell therapy 🤯 tobias-b-huber.bsky.social

Excellent lecture and work on the central role of PECs in crescent formation 🌙 by Prof. Pierre-Louis Tharaux at the #PodocyteConference 🐙 tobias-b-huber.bsky.social

Brilliant talk by Prof. Ulf Panzer at the #PodocyteConference 🐙 From immune-profiling to precise treatment 🎯 and a new hypothesis involving Granzyme K in ANCA-GN 🌟 tobias-b-huber.bsky.social

A look into the future by Prof. Moin Saleem 🧐 at the #PodocyteConference 🐙 Walking towards gene therapy in Glomerular Diseases 🧬🤯 kidneyresearchuk.org‬ tobias-b-huber.bsky.social

Prof. dannygale.bsky.social‬ enlightens how studying large cohorts, such as the RaDaR Registry, allows for deeper understanding and gap closing in rare diseases 🔑 #PodocyteConference 🐙 ukkidney.org‬ tobias-b-huber.bsky.social

Update of the current trials in complement-mediated glomerulopathies by Marina Vivarelli 🌟 Exclusive sneak peek into new trial data for #PodocyteConference attendants 🤓 🐙 tobias-b-huber.bsky.social erknet.bsky.social‬

Wonderful to be at the 15th International Podocyte Conference in Hamburg! Exciting science & fabulous networking ❤️ Huge 🙏 to @tobias-b-huber.bsky.social & @isgd.bsky.social teams 🙏